与单独的内镜治疗相比,在性结肠炎患者中进行的外腔治疗改善了长期的结果
Chong-Teik Lim1,2, Christoph Teichert1, Maarten Pruijt1
1Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
Journal of Crohn's & colitis
|August 22, 2025
概括
通过肠道超声波评估的性结肠炎 (UC) 的外观愈合与单独的内观愈合 (EH) 相比,与更低的复发风险有关. 这表明IUS可以帮助预测UC患者的复发风险.
科学领域:
- 胃肠病学
- 炎症性肠道疾病
- 医学成像
背景情况:
- 内镜治疗 (EH) 是性结肠炎 (UC) 的一个关键治疗目标.
- 通过肠道超声波 (IUS) 的评估可以提供进一步的预后洞察力.
- 这项研究比较了基于TH和单独EH的UC患者的结果.
研究的目的:
- 通过肠道超声波 (IUS) 评估的UC中透口愈合 (TH) 是否与患者的改善结果相关.
- 为了比较UC患者的无复发存活率.
- 评估IUS作为评估UC治愈和预测复发的工具.
主要方法:
- 在61名内透视治愈的UC患者中进行了回顾性研究 (EH; MES ≤1).
- 在内镜检查后6个月内进行肠道超声波 (IUS); TH定义为肠壁厚度< 3毫米.
- 主要结果:没有复发的生存率;用于分析的多变量考克斯回归.
主要成果:
- 72% 的患者在静脉注射上实现了 TH.
- 在TH患者中,第一年复发的风险显著降低 (7. 5%),而非TH患者 (29. 4%; p=0. 004).
- 非TH (HR,3. 99) 和女性性别与复发相关,而EH水平则没有.
结论:
- 与仅使用内镜治疗 (EH) 相比,在UC患者中进行外腔治疗 (TH) 与复发风险降低有关.
- 肠道超声波 (IUS) 提供了一种非侵入性的,具有成本效益的方法来评估UC愈合.
- 可以通过复发风险对UC患者进行分层.
相关概念视频
01:21Inflammatory Bowel Disease V: Surgical Management
212
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
212
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
321
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
321
01:29Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
01:26Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145